ArticleCancers2024

Chimeric Antigen Receptor-Modified T Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: Promise and Potential.

Leah R Tharian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.